Clinical Trial Update: Semmelweis Esophageal Cancer Study: Noninvasive Prognostic Parameters in Patients With Oesophageal and Esophagogastric Junction Cancer

View source ↗

Summary

A Semmelweis University study evaluating noninvasive prognostic parameters for esophageal cancer and the esophagogastric junction cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Esophagogastric Junction Cancer

Snippet

Sponsor: Semmelweis University | Conditions: Esophageal Cancer (EsC) | Status: RECRUITING